Neladalkib

Neladalkib CAS 2739866-40-9 MF C23H22ClFN6O MW 452.9 g/mol FDA 2026, APPROVALS 2026, Nelkarmi (19R)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,10,11,23-pentazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(25),2(6),4,8,11,13(18),14,16,21,23-decaen-22-amine anaplastic lymphoma kinase (ALK) inhibitor, antineoplastic, NVL-655, NVL 655, J32P26A6BC, ALK-IN-27 To treat locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer after certain previous therapiesNeladalkib is a small molecule drug. The usage of the INN stem ‘-alkib’ in the … Continue reading Neladalkib